Guilin Three Gorges Pharmaceutical

Guilin Three Gorges Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a subsidiary of China Resources Sanjiu Medical & Pharmaceutical. Established in 1969, the company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosage forms, with a strong focus on oncology and cardiovascular health. Its flagship product, L-asparaginase, is a critical therapeutic for acute lymphoblastic leukemia, making the company a significant player in the specialized biologics market. Additionally, the firm produces a range of cardiovascular treatments, including amiodarone hydrochloride, and maintains high-standard GMP manufacturing facilities in Guilin. As part of the China Resources Group, it leverages extensive distribution networks to supply essential medicines across China and international markets.